119 related articles for article (PubMed ID: 7630156)
1. Comparison of the stereoselective effects of a thiadiazinone derivative on contractile parameters and protein phosphorylation in the mammalian ventricle.
Neumann J; Bokník P; Schmitz W; Scholz H; Zimmermann N
J Cardiovasc Pharmacol; 1995 May; 25(5):789-93. PubMed ID: 7630156
[TBL] [Abstract][Full Text] [Related]
2. The novel cardiotonic agent EMD 53 998 is a potent "calcium sensitizer".
Beier N; Harting J; Jonas R; Klockow M; Lues I; Haeusler G
J Cardiovasc Pharmacol; 1991 Jul; 18(1):17-27. PubMed ID: 1719287
[TBL] [Abstract][Full Text] [Related]
3. EMD 53998 acts as Ca(2+)-sensitizer and phosphodiesterase III-inhibitor in human myocardium.
Uhlmann R; Schwinger RH; Lues I; Erdmann E
Basic Res Cardiol; 1995; 90(5):365-71. PubMed ID: 8585857
[TBL] [Abstract][Full Text] [Related]
4. The two mechanisms of action of racemic cardiotonic EMD 53998, calcium sensitization and phosphodiesterase inhibition, reside in different enantiomers.
Lues I; Beier N; Jonas R; Klockow M; Haeusler G
J Cardiovasc Pharmacol; 1993 Jun; 21(6):883-92. PubMed ID: 7687712
[TBL] [Abstract][Full Text] [Related]
5. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation.
Haikala H; Nissinen E; Etemadzadeh E; Levijoki J; Lindén IB
J Cardiovasc Pharmacol; 1995 May; 25(5):794-801. PubMed ID: 7630157
[TBL] [Abstract][Full Text] [Related]
6. A novel thiadiazinone derivative fully reverses acidosis-induced depression of force in cardiac muscle by a calcium-sensitizing effect.
Lee JA; Shah N; White J; Orchard CH
Clin Sci (Lond); 1993 Feb; 84(2):141-4. PubMed ID: 8382578
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of the contractile effects of flosequinoxan.
Zimmermann N; Bodor GS; Boknik P; Gams E; Jones LR; Neumann J; Scholz H
Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):385-90. PubMed ID: 7630429
[TBL] [Abstract][Full Text] [Related]
8. Different chronotropic and inotropic effects of EMD 57033 and EMD 53998, Ca2+ sensitizers, on isolated, blood-perfused dog heart preparations.
Lakhe M; Furukawa Y; Yonezawa T; Hirose M; Nagashima Y; Miyashita Y; Chiba S
Jpn J Pharmacol; 1998 Apr; 76(4):435-9. PubMed ID: 9623723
[TBL] [Abstract][Full Text] [Related]
9. Ca2+ sensitizing effects of EMD 53998 after troponin replacement in skinned fibres from porcine atria and ventricles.
Barth Z; Strauss JD; Heyder S; Van Eyk J; Wiesner RJ; Rüegg JC
Pflugers Arch; 1995 Jun; 430(2):220-9. PubMed ID: 7675632
[TBL] [Abstract][Full Text] [Related]
10. Characterization of biochemical effects of CGS 21680C, an A2-adenosine receptor agonist, in the mammalian ventricle.
Bokník P; Neumann J; Schmitz W; Scholz H; Wenzlaff H
J Cardiovasc Pharmacol; 1997 Dec; 30(6):750-8. PubMed ID: 9436814
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of the contractile effects of levosimendan in the mammalian heart.
Bokník P; Neumann J; Kaspareit G; Schmitz W; Scholz H; Vahlensieck U; Zimmermann N
J Pharmacol Exp Ther; 1997 Jan; 280(1):277-83. PubMed ID: 8996207
[TBL] [Abstract][Full Text] [Related]
12. Interaction of cardiac troponin C with Ca(2+) sensitizer EMD 57033 and cardiac troponin I inhibitory peptide.
Li MX; Spyracopoulos L; Beier N; Putkey JA; Sykes BD
Biochemistry; 2000 Aug; 39(30):8782-90. PubMed ID: 10913289
[TBL] [Abstract][Full Text] [Related]
13. Effects of levosimendan on myocardial contractility and Ca2+ transients in aequorin-loaded right-ventricular papillary muscles and indo-1-loaded single ventricular cardiomyocytes of the rabbit.
Sato S; Talukder MA; Sugawara H; Sawada H; Endoh M
J Mol Cell Cardiol; 1998 Jun; 30(6):1115-28. PubMed ID: 9689586
[TBL] [Abstract][Full Text] [Related]
14. Novel diazinone derivatives separate myofilament Ca2+ sensitization and phosphodiesterase III inhibitory effects in guinea pig myocardium.
Ventura C; Miller R; Wolf HP; Beier N; Jonas R; Klockow M; Lues I; Hano O; Spurgeon HA; Lakatta EG
Circ Res; 1992 Jun; 70(6):1081-90. PubMed ID: 1533576
[TBL] [Abstract][Full Text] [Related]
15. In vivo evidence of positive inotropism of EMD 57033 through calcium sensitization.
Haeusler G; Jonas R; Minck KO; Schliep HJ; Schelling P; Weygandt H; Lues I
J Cardiovasc Pharmacol; 1997 May; 29(5):647-55. PubMed ID: 9213208
[TBL] [Abstract][Full Text] [Related]
16. EMD 53998 sensitizes the contractile proteins to calcium in intact ferret ventricular muscle.
Lee JA; Allen DG
Circ Res; 1991 Oct; 69(4):927-36. PubMed ID: 1934345
[TBL] [Abstract][Full Text] [Related]
17. Effects of the Ca2+ sensitizers EMD 57033 and CGP 48506 on myocardial contractility and Ca2+ transients in human ventricular and atrial myocardium.
Brixius K; Reicke S; Reuter H; Schwinger RH
Z Kardiol; 2002 Apr; 91(4):312-8. PubMed ID: 12063703
[TBL] [Abstract][Full Text] [Related]
18. [The Ca(2+) sensitizers CGP 48506 and EMD 57033, but not the Na(+) channel modulator BDF 9148, prolong relaxation in isolated cardiomyocytes of the guinea pig].
Brixius K; Hoischen S; Zobel C; Lasek K; Schwinger RH
Z Kardiol; 2001 Apr; 90(4):286-91. PubMed ID: 11381577
[TBL] [Abstract][Full Text] [Related]
19. Stereoselectivity of actions of the calcium sensitizer [+]-EMD 60263 and its enantiomer [-]-EMD 60264.
Ravens U; Flüss OM; Li Q; Himmel HM; Wettwer E; Klockow M; Lues I
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):733-42. PubMed ID: 9205958
[TBL] [Abstract][Full Text] [Related]
20. A new cardiotonic drug reduces the energy cost of active tension in cardiac muscle.
Gross T; Lues I; Daut J
J Mol Cell Cardiol; 1993 Mar; 25(3):239-44. PubMed ID: 8510167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
